Literature DB >> 24184605

Nucleolar dysfunction in Huntington's disease.

Junghee Lee1, Yu Jin Hwang2, Hyun Ryu3, Neil W Kowall1, Hoon Ryu4.   

Abstract

Huntington's disease (HD) is a fatal genetic disorder characterized by triad clinical symptoms of chorea, emotional distress, and cognitive decline. Genetic mutation in HD is identified by an expansion of CAG repeats coding for glutamine (Q) in exon 1 of the huntingtin (htt) gene. The exact mechanism on how mutant htt leads to the selective loss of medium spiny neurons (MSNs) in the striatum is still unknown. Recent studies suggest that nucleolar stress and dysfunction are linked to the pathogenesis of HD. Alterations of the nucleolar activity and integrity contribute to deregulation of ribosomal DNA (rDNA) transcription in HD pathogenesis. Furthermore, epigenetic modifications in the nucleolus are associated with neuronal damage in HD. In this review, we discuss about how post-translational modifications of upstream binding factor (UBF) are affected by histone acetyltransferase and histone methyltransferase and involved in the transcriptional regulation of rDNA in HD. The understanding of epigenetic modulation of UBF-dependent rDNA transcription in the nucleolus may lead to the identification of novel pathological markers and new therapeutic targets to treat HD. This article is part of a Special Issue entitled: Role of the Nucleolus in Human Disease.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetylation and methylation; Epigenetics; Huntington's disease; Nucleolus; Upstream binding factor (UBF); rDNA transcription

Mesh:

Substances:

Year:  2013        PMID: 24184605      PMCID: PMC3972370          DOI: 10.1016/j.bbadis.2013.09.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  61 in total

1.  Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport.

Authors:  Györgyi Szebenyi; Gerardo A Morfini; Alyssa Babcock; Milena Gould; Kimberly Selkoe; David L Stenoien; Maureen Young; Pieter W Faber; Marcy E MacDonald; Michael J McPhaul; Scott T Brady
Journal:  Neuron       Date:  2003-09-25       Impact factor: 17.173

Review 2.  Histone methylation: dynamic or static?

Authors:  Andrew J Bannister; Robert Schneider; Tony Kouzarides
Journal:  Cell       Date:  2002-06-28       Impact factor: 41.582

Review 3.  Experimental therapeutics in transgenic mouse models of Huntington's disease.

Authors:  M Flint Beal; Robert J Ferrante
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

4.  Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor.

Authors:  Liu Yang; Li Xia; Daniel Y Wu; Hengbin Wang; Howard A Chansky; William H Schubach; Dennis D Hickstein; Yi Zhang
Journal:  Oncogene       Date:  2002-01-03       Impact factor: 9.867

Review 5.  Protein aggregation and neurodegenerative disease.

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

6.  CBP histone acetyltransferase activity is a critical component of memory consolidation.

Authors:  Edward Korzus; Michael G Rosenfeld; Mark Mayford
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

7.  Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.

Authors:  Eugenia Trushina; Roy B Dyer; John D Badger; Daren Ure; Lars Eide; David D Tran; Brent T Vrieze; Valerie Legendre-Guillemin; Peter S McPherson; Bhaskar S Mandavilli; Bennett Van Houten; Scott Zeitlin; Mark McNiven; Ruedi Aebersold; Michael Hayden; Joseph E Parisi; Erling Seeberg; Ioannis Dragatsis; Kelly Doyle; Anna Bender; Celin Chacko; Cynthia T McMurray
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

8.  Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration.

Authors:  Juan M Alarcón; Gaël Malleret; Khalid Touzani; Svetlana Vronskaya; Shunsuke Ishii; Eric R Kandel; Angel Barco
Journal:  Neuron       Date:  2004-06-24       Impact factor: 17.173

9.  Depletion of wild-type huntingtin in mouse models of neurologic diseases.

Authors:  Yu Zhang; Mingwei Li; Martin Drozda; Minghua Chen; Shengjun Ren; Rene O Mejia Sanchez; Blair R Leavitt; Elena Cattaneo; Robert J Ferrante; Michael R Hayden; Robert M Friedlander
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

Review 10.  Dysfunction of wild-type huntingtin in Huntington disease.

Authors:  Elena Cattaneo
Journal:  News Physiol Sci       Date:  2003-02
View more
  24 in total

1.  Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood.

Authors:  Simon Edvardson; Claudia M Nicolae; Pankaj B Agrawal; Cyril Mignot; Katelyn Payne; Asuri Narayan Prasad; Chitra Prasad; Laurie Sadler; Caroline Nava; Thomas E Mullen; Amber Begtrup; Berivan Baskin; Zöe Powis; Avraham Shaag; Boris Keren; George-Lucian Moldovan; Orly Elpeleg
Journal:  Am J Hum Genet       Date:  2017-08-03       Impact factor: 11.025

Review 2.  Insights into the regulation of neuronal viability by nucleophosmin/B23.

Authors:  Jason A Pfister; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

3.  The autophagic protein LC3 translocates to the nucleus and localizes in the nucleolus associated to NUFIP1 in response to cyclic mechanical stress.

Authors:  Myoung Sup Shim; April Nettesheim; Joshua Hirt; Paloma B Liton
Journal:  Autophagy       Date:  2019-09-16       Impact factor: 16.016

4.  Subjects At-Risk for Genetic Diseases in Portugal: Illness Representations.

Authors:  Ângela Leite; Maria Alzira P Dinis; Jorge Sequeiros; Constança Paúl
Journal:  J Genet Couns       Date:  2015-05-19       Impact factor: 2.537

5.  Repeat RNA Toxicity Drives Ribosomal RNA Processing Defects in SCA2.

Authors:  Geena Skariah; Roger Lee Albin
Journal:  Mov Disord       Date:  2021-11       Impact factor: 10.338

Review 6.  Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies.

Authors:  Michal Hetman; Lukasz P Slomnicki
Journal:  J Neurochem       Date:  2018-11-12       Impact factor: 5.372

7.  Regulation of Neuronal Survival by Nucleophosmin 1 (NPM1) Is Dependent on Its Expression Level, Subcellular Localization, and Oligomerization Status.

Authors:  Jason A Pfister; Santosh R D'Mello
Journal:  J Biol Chem       Date:  2016-08-10       Impact factor: 5.157

Review 8.  Invited review: decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art.

Authors:  Matthew J Walsh; Johnathan Cooper-Knock; Jennifer E Dodd; Matthew J Stopford; Simeon R Mihaylov; Janine Kirby; Pamela J Shaw; Guillaume M Hautbergue
Journal:  Neuropathol Appl Neurobiol       Date:  2015-02       Impact factor: 8.090

9.  Compensatory Motor Neuron Response to Chromatolysis in the Murine hSOD1(G93A) Model of Amyotrophic Lateral Sclerosis.

Authors:  Javier Riancho; Maria Ruiz-Soto; Nuria T Villagrá; Jose Berciano; Maria T Berciano; Miguel Lafarga
Journal:  Front Cell Neurosci       Date:  2014-10-22       Impact factor: 5.505

Review 10.  Assemblages: functional units formed by cellular phase separation.

Authors:  Jeffrey A Toretsky; Peter E Wright
Journal:  J Cell Biol       Date:  2014-09-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.